ChinaTalk
Subscribe
Sign in
Home
Podcast
Merch
AI
Semiconductors
US-China
War
Content by Topic
About
Biotech
US-China Biorisk Cooperation: Yes, It’s Possible
The U.S. AI CEOs all want to screen dangerous biological orders. Coming to an agreement with China is the next step.
Sep 8
•
Nick Corvino
54
4
4
The Monkey Supply Chain
Is China's monkey monopoly unbreakable?
Jul 14
•
Nick Corvino
80
9
10
The Empire of Wuxi
China's Biotech Giant
May 19
•
Nick Corvino
86
7
12
Clinical Trial Abundance, Made in China
Flying to China for cancer care
Apr 17
•
Jacob Stern
96
3
17
Chinese Peptides
A special report!
Feb 20
•
Lily Ottinger
,
Irene Zhang
,
Nick Corvino
, and
Jasmine Sun
45
2
6
How China's Preparing for the Next Pandemic
Beijing doesn’t want COVID-2.0—but what have they learned?
Dec 17, 2025
•
Nick Corvino
28
2
8
Biotech
A Feature: China's Coming of Age
Jun 9, 2025
•
Angela Shen
54
1
9
A Biotech Strategy Toolkit
capital, talent, and supply chains
May 1, 2025
•
Angela Shen
22
5
Pharma Access with Chinese Characteristics
How policy shapes drug availability
Mar 26, 2025
•
Angela Shen
30
2
10
Innovation and AI in China’s Biotech Sector
Owing to reg reform and a strong innovation ecosystem, China’s biopharma industry has bloomed — bringing attendant political controversy but also…
Sep 24, 2024
•
Nicholas Welch
and
Angela Shen
34
8
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
